Exevir Bio

Exevir Bio is a company in Gent, Belgium that has taken part in 1 EU-funded project since 2021, receiving €6.6M in EU funding and leading 1 as coordinator.

EU funding received€6.6M
EU projects1
As coordinator1
Running now0
First EU project2021
Latest project2021
CountryBelgium
EU registration (PIC)891045784
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Exevir Bio's own share of each project, not the project's full budget.

  • Horizon Europe€6.6M · 1 project

Projects

1 EU-funded project, newest first. Exevir Bio led 1 of them as coordinator. Each links to the official record.

  • XVR011 Phase 2Coordinator

    ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2

    Horizon Europe · 2021–2022 · Project on CORDIS ↗

    €6.6Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • entrepreneurship
  • pandemics
  • proteins
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime